MedPath

Metabolic Adaptations to High-fat Diet

Not Applicable
Active, not recruiting
Conditions
Insulin Sensitivity
Impaired Glucose Tolerance
Adiposity
Metabolic Disturbance
Registration Number
NCT06537401
Lead Sponsor
George Washington University
Brief Summary

The purpose of this study is to understand how the body's response after a meal is influenced by insulin and sugar in the blood. The primary question this study seeks to address is what is the effect of reduced insulin sensitivity on postprandial metabolic flexibility to an oral glucose tolerance test. We will recruit 50 adults (ages 20-45; 50% female) who are otherwise healthy (no known clinical diagnosis) into our non-randomized crossover trial to determine the effect of changes in insulin sensitivity on metabolic response to feeding. Insulin sensitivity will be decreased using a three-day high-fat diet (HFD) with extra calories. Whole-body metabolism will be measured during a standard 75-gram oral glucose tolerance test (OGTT). Metabolic response to feeding (e.g. OGTT) will be compared before and after the HFD and compared with the control diet to understand the effect of decreased insulin sensitivity on the metabolic response to feeding. The role of biological sex as a moderator of the effect of increased insulin resistance on postprandial metabolic flexibility will also be investigated

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Males or Females between the ages of 20 and 45 years
  • Body mass index (BMI) of 18.5-29.9 kg/m2
  • Low risk for medical complications as determined by physical activity readiness questionnaire (PARQ).
  • Low risk for food insecurity via the Hunger Vital Sign screener
Exclusion Criteria
  • Currently taking any antioxidant supplementation, prescription non-steroidal anti- inflammatory drugs, antibiotics, steroids, probiotics, medications for management of cholesterol, diabetes, body weight/obesity, or are undergoing transgender hormone therapy.
  • Currently pregnant (verified by urine pregnancy test)
  • Any history of disordered eating (i.e., anorexia nervosa, bulimia nervosa, binge eating disorder, etc.) or high risk for disordered eating via validated questionnaire (SCOFF)
  • Any history of gastrointestinal diseases (i.e., gastroesophageal reflux disease, irritable bowel syndrome, Celiac disease, Crohn's disease, or lactose intolerance)
  • Allergies to wheat or gluten, milk, soy, tree nuts (e.g., almonds, walnuts, pecans), or peanuts.
  • Followed a ketogenic diet within the last three months
  • Instructed by a medical provided to avoid a high-fat diet due to cardiovascular disease risk.
  • Cardiorespiratory fitness (VO2max) greater than the 90th percentile for age and sex

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Postprandial Metabolic Flexibility3 Days

Mean difference respiratory exchange ratio during an oral glucose tolerance test following a high fat diet

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

George Washington University School of Public Health

🇺🇸

Washington, District of Columbia, United States

George Washington University School of Public Health
🇺🇸Washington, District of Columbia, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.